The global birch allergy treatment market is experiencing significant growth, with a market value of USD 571 million in 2023. Projections indicate that the market is set to nearly double, reaching USD 1123.24 Million by 2033. This impressive growth reflects a compound annual growth rate (CAGR) of 7% during the forecast period from 2023 to 2033.
Birch pollen allergy, a common seasonal affliction affecting millions globally, has driven the demand for effective treatments in recent years. With a growing awareness of allergy-related health issues, coupled with advancements in immunotherapy and drug development, the birch allergy treatment market is positioned for substantial expansion.
One of the most promising developments in the Birch Allergy Treatment Market is the use of immunotherapy. Immunotherapy is a treatment that involves exposing a patient to gradually increasing doses of an allergen, such as birch pollen. The idea behind this treatment is to desensitize the patient’s immune system to the allergen, which can help reduce or even eliminate allergic reactions.
In addition to traditional treatment options, there has also been a growing interest in alternative therapies for the treatment of birch allergy. These therapies include acupuncture, herbal remedies, and homeopathy. While the efficacy of these treatments is still being studied, they have shown promising results in some cases and may provide additional treatment options for birch allergy sufferers.
Key Takeaways from the Market Study:
- The Birch allergy treatment market is expected to grow at a value of 7% CAGR in the forecast period 2023-2033
- Oral route of administration is expected to hold 53% of the market share in 2023 for Birch allergy treatment market.
- North America is expected to possess 48% market share for Birch allergy treatment market in 2023.
- Europe Birch allergy treatment market size is expected to possess 43% market share in 2023.
“Significant increase in the number of drugs and therapies available for the treatment of birch allergy is not only increasing treatment options for patients but has also has made treatments more effective and efficient.” states an FMI analyst
Heightened Demand for Market Data: Our Full Report Provides Extensive Trend Analysis!
Competitive Landscape:
Key players in the Birch allergy treatment market are Allergy Therapeutics Plc, Regeneron Pharmaceuticals Inc, Desentum, HAL Allergy Group, Roxall Medizin GmbH, Worg Pharmaceuticals AG, S-TARget therapeutics GmbH, Adamis Pharmaceuticals Corporation, Merck KGaA and Stallergenes Greer plc
- Allergy Therapeutics Plc is a biopharmaceutical company that specializes in developing immunotherapy products for the treatment of allergies, including birch allergy. The company has developed a range of products for the treatment of birch allergy, including subcutaneous and sublingual immunotherapies.
- Desentum’s product for birch allergy is called ASIT+TM Birch, which is a vaccine that combines Desentum’s proprietary peptide-based technology with an adjuvant to enhance the immune response.
Key Segments Profiled in the Birch Allergy Treatment Market Industry Survey:
Drug Class:
- Antihistamines
- Cetirizine
- Diphenhydramine
- Decongestant
- Pseudoephedrine
- Oxymetazoline
Route of Administration:
- Oral
- Intranasal
Distribution Channel:
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube